(NP (NP (NP Membrane/NN receptors/NNS) (PP for/IN (NP aldosterone/NN)) :/:) (NP (NP a/DT novel/JJ pathway/NN) (PP for/IN (NP mineralocorticoid/NN action/NN)) ./.))
(S (NP-SBJ-2 (NP Rapid/JJ nongenomic/JJ (ADJP in/FW vitro/FW) effects/NNS) (PP of/IN (NP aldosterone/NN)) (PP on/IN (NP-COOD (NP intracellular/JJ electrolytes/NNS) ,/, (NP cell/NN volume/NN) ,/, and/CC (NP Na-LRB-+-RRB--H+/JJ antiport/NN)))) (VP have/VBP (VP been/VBN (VP found/VBN (NP *-2/-NONE-) (PP in/IN (NP (NP human/JJ mononuclear/JJ leukocytes/NNS) (PRN -LRB-/-LRB- (NP HML/NN) -RRB-/-RRB-)))))) ./.)
(S (NP-SBJ (NP Binding/NN) (PP of/IN (NP 125I-labeled/JJ aldosterone/NN)) (PP to/TO (NP (NP plasma/NN membranes/NNS) (PP of/IN (NP HML/NN))))) (VP shares/VBZ (NP important/JJ features/NNS) (PP with/IN (NP these/DT functional/JJ data/NNS))) ./.)
(S (NP-SBJ This/DT) (VP includes/VBZ (NP-COOD (NP (NP (NP a/DT (ADJP very/RB low/JJ) apparent/JJ (NP (NP dissociation/NN constant/NN) (PRN -LRB-/-LRB- (NP Kd/NN) -RRB-/-RRB-))) (PP of/IN (NP 0.1/CD nM/NN))) (PP for/IN (NP-COOD both/CC (NP aldosterone/NN) and/CC (NP (NP the/DT effect/NN) (PP on/IN (NP the/DT Na-LRB-+-RRB--H-LRB-+-RRB--antiport/NN)))))) ,/, (NP a/DT high/JJ turnover/NN rate/NN) ,/, and/CC (NP (NP the/DT (ADJP almost/RB exclusive/JJ) binding/NN selectivity/NN) (PP for/IN (NP aldosterone/NN))))) ./.)
(S (NP-SBJ-COOD (NP Dexamethasone/NN) ,/, (NP RU/NN 26988/CD) ,/, (NP corticosterone/NN) ,/, (NP ouabain/NN) ,/, (NP amiloride/NN) ,/, and/CC (NP 18-hydroxyprogesterone/NN)) (VP were/VBD (ADJP-PRD inactive/JJ) (PP as/IN (NP ligands/NNS))) ./.)
(S (NP-SBJ Deoxycorticosterone/NN acetate/NN) (VP had/VBD (NP an/DT intermediate/JJ activity/NN) (PP with/IN (NP (NP an/DT apparent/JJ Kd/NN) (PP of/IN (NP 100/CD nM/NN))))) ./.)
(S (NP-SBJ These/DT findings/NNS) (VP are/VBP (NP-PRD (NP the/DT first/JJ) (SBAR (WHNP-101 0/-NONE-) (S (NP-SBJ *T*-101/-NONE-) (VP to/TO (VP demonstrate/VB (S (NP-SBJ (NP membrane/NN binding/NN) (PP of/IN (NP aldosterone/NN))) (VP being/VBG (ADJP-PRD compatible/JJ (PP with/IN (NP (NP major/JJ aspects/NNS) (PP of/IN (NP its/PRP$ nongenomic/JJ effects/NNS))))))))))))) ./.)
